Use of adenovirus type-5 vectored vaccines: a cautionary tale

Lancet. 2020 Oct 31;396(10260):e68-e69. doi: 10.1016/S0140-6736(20)32156-5. Epub 2020 Oct 19.

¹ Bridge HIV, San Francisco Department of Public Health, San Francisco, CA 94102, USA; Department of Medicine and Department of Epidemiology, University of California, San Francisco, CA, USA. Electronic address: susan.buchbinder@sfdph.org.
² Fred Hutchinson Cancer Research Institute, Seattle, WA, USA; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, University of Washington, Seattle, WA, USA.
³ Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

No abstract available

Publication types